Find Resources
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Peer Review Study
This paper analyzes the policy components that contribute to the programmatic success of flu and Tdap pregnancy vaccine programs in three high-income countries, including the United States. Key pillars to increased vaccination coverage include Health Authority accountability, facilitated patient access to vaccination, healthcare professional accountability and engagement, awareness of the burden and severity of diseases, and finally, belief in the benefits of pregnancy vaccination. In the US, given the higher diversity of stakeholders, a multi-stakeholder approach with calls to action from the CDC and endorsement from other scientific societies were key to uptake of vaccinations in pregnancy. It is recommended that maternal task forces reinforce these messages, disseminate toolkits, and that partners address barriers that stand in the way of vaccination, including ensuring that vaccination clinics are convenient for pregnant woman. Successful programs do not require implementation of all components; instead, public health experts should use these as components as guiding tools that can be refined depending on the specificities of the healthcare system in place.
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Peer Review Study, Summary Report/Recommendations
The guidance outlined in this report provides a roadmap for the ethical inclusion of pregnant women’s experiences in in the development and deployment of vaccines against emerging viruses. Recommendations include bolstering health information surveillance systems, stakeholder engagement with health care, women, families and communities, and changing the narrative about pregnancy and clinical research efforts. Recommendations require commitment of financial resources, addressing inequities in public health and whenever possible, the inclusion of perspectives of pregnant women. Lastly, the authors recommend that “When there is a limited supply of vaccine against a pathogenic threat that disproportionately affects pregnant women, their offspring, or both, or when only one vaccine among several is appropriate for use in pregnancy, then pregnant women should be among the priority groups to be offered the vaccine.” This prioritization process is key to addressing inequities and are guidance for future pandemic response efforts.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Peer Review Study
Maternity healthcare professionals (MHCPs) play an important role in promoting vaccines and influencing the perspectives of pregnant women. This systematic review outlines the views and experiences of these key workforce members involved in the provision of the maternal influenza vaccine worldwide. In order to promote vaccine uptake, results indicate that it is important to educate MHCPs, ensure there is sufficient time for discussions, and implement electronic vaccination prompts. These, in addition to national policies and guidelines, helped increase the confidence of these professionals in recommending vaccination.
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Peer Review Study
The guidance outlined in this report provides a roadmap for the ethical inclusion of pregnant women’s experiences in the development and deployment of vaccines against emerging viruses. Recommendations include (1) bolstering health information surveillance systems, (2) stakeholder engagement with health care, women, families and communities, and (3) changing the narrative about pregnancy and clinical research efforts. Recommendations require commitment of financial resources, addressing inequities in public health, and whenever possible, the inclusion of perspectives of pregnant women. Lastly, the authors recommend that “When there is a limited supply of vaccine against a pathogenic threat that disproportionately affects pregnant women, their offspring, or both, or when only one vaccine among several is appropriate for use in pregnancy, then pregnant women should be among the priority groups to be offered the vaccine.” This prioritization process is key to addressing inequities and are guidance for future pandemic response efforts.
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
Peer Review Study
This study aimed to determine independent community pharmacist preparedness for COVID-19 vaccination and to identify strategies for COVID-19 vaccination implementation in Pennsylvania. Through surveys and focus groups these recommendations emerged: (1) working with community partners to support off-site mass vaccination clinics, (2) leverage partnerships with community organizations and universities to support staffing for vaccination efforts, (3) use an appointment-based immunization model, (4) use existing scheduling tools, text messaging, and automated phone calls for second-dose reminders, and (5) further training and process improvements to support vaccine documentation and transmission to the Pennsylvania Statewide Immunization Information System.
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
Peer Review Study
In the United States, mobile health clinics are an important method for delivering high quality care to medically underserved populations. To address declining vaccination coverage among young children in Boston during the pandemic, Mattapan Community Health Center (Mattapan) and Codman Square Health Center (Codman Square) partnered with the Kraft Center for Community Health at Massachusetts General Hospital and the Massachusetts League of Community Health Centers to deploy a pediatric mobile health clinic as an adjunct to their in-person clinical services.
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
Peer Review Study
This cross-sectional study assessed vaccine uptake in staff and residents of long-term care facilities, including assisted living and other residential care through the Pharmacy Partnership for Long-Term Care Program. This program, a public-private partnership with 3 pharmacies (CVS, Managed Health Care Associates, and Walgreens), conducted on-site visits to enrolled LTCFs to provide end-to-end management of the COVID-19 vaccination process, including appropriate storage, handling, and transport of vaccines; vaccine administration; and fulfillment of reporting requirements. Findings include having on site clinics may increase vaccine uptake, particularly when transportation may be a barrier and recommendations include ensuring steady access to COVID-19 vaccine in LTCFs following the end of the Pharmacy Partnership to maintain high vaccination coverage among residents and staff.
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
Peer Review Study
This case study is on the effectiveness of COVID-19 vaccine distribution via mobile vans to residents/staff of 47,907 long-term care facilities (LTCFs) across the United States that relied on algorithms to optimize vaccine distribution. The authors developed a modeling framework for vaccine distribution to high-risk populations in a supply-constrained environment. The framework decomposed this challenge as two separate problems: an assignment problem, where they optimally mapped each LTCF to select CVS stores responsible for vaccines; and a scheduling problem, where they developed an algorithm to assign available resources efficiently. The learning and this framework may be of use to other organizations, including communities where mobile clinics can be established to efficiently distribute vaccines and other healthcare resources in a variety of scenarios.
Novel Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and are in the process of generating evidence of effectiveness or may not yet be tested.
RELEASE DATE:
Peer Review Study
This survey study of health care workers in two academic hospitals, one adult and one child, presents findings on the differences in COVID-19 vaccine hesitancy by race/ethnicity among health care workers. Striking differences were found across race and ethnic groups regarding reported vaccine hesitancy with Whites, on average, having the lowest level of hesitancy. Hesitancy was defined as not planning on, being unsure, or planning to delay getting a COVID-19 vaccine. Black, Asian, Hispanic or Latino, and mixed-race participants were more hesitant than Whites. Reasons for hesitancy include concern regarding side effects, the newness of the vaccine, and lack of vaccine knowledge.
Novel Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and are in the process of generating evidence of effectiveness or may not yet be tested.
RELEASE DATE:
Peer Review Study
This article presents findings from a study that assessed published COVID-19 vaccine allocation plans for the Center for Disease Control and Prevention’s (CDC) 64 jurisdictions. The analysis reflects assessments of the plans between November 2020 and March 2021. The authors question whether the plans prioritized zip codes based on calculated disadvantage indices, which are based on area-level indicators (e.g., U.S. Census data). By the end of the period under investigation, 37 jurisdictions had adopted disadvantage scales. Key themes include: (1) Prioritizing disadvantaged groups, (2) Defining priority groups or areas, (3) Tailoring outreach and communication, (4) Planning the location of dispensing sites, and (5) Monitoring receipt of the COVID-19 vaccine.